Prenaital
Prenaital is an AI-driven healthcare company, to revolutionizing maternal care by improving detection & management of high-risk pregnancies.
Prenaital is an AI-driven healthcare company, to revolutionizing maternal care by improving detection & management of high-risk pregnancies.
Prenaital has raised $1.6M across 1 round. Its most recent round was a Seed of $1.6M in Sep 2025. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Prenaital is featured in
Similar companies
LaFraise develops artificial intelligence agents specifically for dentists to automate administrative processes.
Flyway Health is a healthtech company that offers brand-tailored AI agents for healthcare assistance.
OrahVision offers AI driven technology that allows people with low vision to read and interact with books, documents, and text naturally.
Yuanhe Vision is a high-tech enterprise specializing in AI-assisted ophthalmic diagnosis and optometry technology.
Monsana offers an AI-powered platform that connects eligible participants to relevant clinical trials throughout Europe.
The Hub is a recruitment platform for Nordic startups that offers career opportunities for global talents.
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications. The Company has developed a highly specific PET (Positron emission tomography) imaging ligand, uTRACE®, targeting the receptor uPAR, which is a biomarker only expressed in cancer. uTRACE® will become a game-changer in the diagnosis and treatment of cancer patients. In addition, with the promising results obtained within diagnostics Curasight will also pursues uPAR targeted radionuclide therapy using the uTREAT® ligand. As PET imaging and radionuclide therapy is based on the same uPAR binding peptide, a uTRACE® scan can precisely predict where subsequent targeted radiation therapy will be delivered. uTRACE® covers the diagnostic path and uTREAT® covers the therapy. This will be the new management and treatment of cancer patients in the future.
Acodyne is made for delivering cargo in difficult-to-reach locations for both military and commercial uses. Middle-mile logistics is being revolutionized globally by Acodyne's creation of the quickest unmanned eVTOL aircraft for large payloads.
TechBBQ is a non-profit event management organization that hosts startup capital programs.
Kvasir Technologies is a firm that has created a game-changing method to manufacture environmentally acceptable fuel for difficult-to-abate industries.
Franklin Technologies is a fintech company that provides e-commerce finance, payment cards, and automated accounting solutions.
Festina Lente is a company that specializes in providing knowledge-based solutions. Our focus is on developing advisory systems that provide individuals with a comprehensive understanding of their finances.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.